Zeprumetostat
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Zeprumetostat, covering 2026-01-14 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell Lymphoma [Phase 1, Phase 2]